131 related articles for article (PubMed ID: 28251496)
21. [Research Progress on the Role of Chromatin Remodeling Factor BRG1 in Acute Myeloid Leukemia].
Gao S; Xu XJ; Zhang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):930-3. PubMed ID: 27342536
[TBL] [Abstract][Full Text] [Related]
22. FGF-2 expression and its action in human leukemia and lymphoma cell lines.
Krejci P; Faitova J; Laurell H; Hampl A; Dvorak P
Leukemia; 2003 Apr; 17(4):818-20. PubMed ID: 12682649
[No Abstract] [Full Text] [Related]
23. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
[TBL] [Abstract][Full Text] [Related]
25. Brahma-related gene 1 (Brg1) epigenetically regulates CAM activation during hypoxic pulmonary hypertension.
Chen D; Fang F; Yang Y; Chen J; Xu G; Xu Y; Gao Y
Cardiovasc Res; 2013 Dec; 100(3):363-73. PubMed ID: 24042015
[TBL] [Abstract][Full Text] [Related]
26. Propofol post-conditioning alleviates hepatic ischaemia reperfusion injury via BRG1-mediated Nrf2/HO-1 transcriptional activation in human and mice.
Ge M; Chen H; Zhu Q; Cai J; Chen C; Yuan D; Jin Y; Yao W; Hei Z
J Cell Mol Med; 2017 Dec; 21(12):3693-3704. PubMed ID: 28749008
[TBL] [Abstract][Full Text] [Related]
27. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
28. Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells.
Wu Q; Sharma S; Cui H; LeBlanc SE; Zhang H; Muthuswami R; Nickerson JA; Imbalzano AN
Oncotarget; 2016 May; 7(19):27158-75. PubMed ID: 27029062
[TBL] [Abstract][Full Text] [Related]
29. Brg1 regulates pro-lipogenic transcription by modulating SREBP activity in hepatocytes.
Li N; Li M; Hong W; Shao J; Xu H; Shimano H; Lu J; Xu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2881-2889. PubMed ID: 29857051
[TBL] [Abstract][Full Text] [Related]
30. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
[TBL] [Abstract][Full Text] [Related]
31. NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.
Nichol JN; Galbraith MD; Kleinman CL; Espinosa JM; Miller WH
Cell Rep; 2016 Mar; 14(12):2938-49. PubMed ID: 26997274
[TBL] [Abstract][Full Text] [Related]
32. Brahma-related gene 1-dependent STAT3 recruitment at IL-6-inducible genes.
Ni Z; Bremner R
J Immunol; 2007 Jan; 178(1):345-51. PubMed ID: 17182572
[TBL] [Abstract][Full Text] [Related]
33. Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury.
Ge M; Yao W; Yuan D; Zhou S; Chen X; Zhang Y; Li H; Xia Z; Hei Z
Cell Death Dis; 2017 Jun; 8(6):e2841. PubMed ID: 28569786
[TBL] [Abstract][Full Text] [Related]
34. Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.
Roy N; Malik S; Villanueva KE; Urano A; Lu X; Von Figura G; Seeley ES; Dawson DW; Collisson EA; Hebrok M
Genes Dev; 2015 Mar; 29(6):658-71. PubMed ID: 25792600
[TBL] [Abstract][Full Text] [Related]
35. SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells.
Kidder BL; Palmer S; Knott JG
Stem Cells; 2009 Feb; 27(2):317-28. PubMed ID: 19056910
[TBL] [Abstract][Full Text] [Related]
36. BRG1 Governs Nanog Transcription in Early Mouse Embryos and Embryonic Stem Cells via Antagonism of Histone H3 Lysine 9/14 Acetylation.
Carey TS; Cao Z; Choi I; Ganguly A; Wilson CA; Paul S; Knott JG
Mol Cell Biol; 2015 Dec; 35(24):4158-69. PubMed ID: 26416882
[TBL] [Abstract][Full Text] [Related]
37. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF
Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040
[TBL] [Abstract][Full Text] [Related]
38. The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells.
Garnier N; Petruccelli LA; Molina MF; Kourelis M; Kwan S; Diaz Z; Schipper HM; Gupta A; del Rincon SV; Mann KK; Miller WH
Leukemia; 2013 Nov; 27(11):2220-8. PubMed ID: 23426167
[TBL] [Abstract][Full Text] [Related]
39. BRG1 is indispensable for IFN-γ-induced TRIM22 expression, which is dependent on the recruitment of IRF-1.
Wang Y; Gao B; Xu W; Xiong S
Biochem Biophys Res Commun; 2011 Jul; 410(3):549-54. PubMed ID: 21683060
[TBL] [Abstract][Full Text] [Related]
40. BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress.
Zhang J; Ohta T; Maruyama A; Hosoya T; Nishikawa K; Maher JM; Shibahara S; Itoh K; Yamamoto M
Mol Cell Biol; 2006 Nov; 26(21):7942-52. PubMed ID: 16923960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
